Gypenoside Inhibits Endothelial Cell Apoptosis in Atherosclerosis by Modulating Mitochondria through PI3K/Akt/Bad PathwayNan Song, Guanlin Yang|BioMed Research International|2020Cited by 45
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory studyHaoran Xia, Gening Jiang, Jing Zhang et al.|Signal Transduction and Targeted Therapy|2024Cited by 30
Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trialChengxiang Yi, Peng Zhang, Dongliang Bian et al.|Nature Communications|2025Cited by 13
Race and Ethnicity, Socioeconomic Factors, and Epigenetic Age Acceleration in Survivors of Childhood CancerCheng Chen, Zhaoming Wang, Noel-Marie Plonski et al.|JAMA Network Open|2024Cited by 9
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Zhaoming Wang, Yue Pan et al.|JNCI Journal of the National Cancer Institute|2024Cited by 2